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Failure of Steroid Sulfatase to Desulfate Vitamin D3 Sulfate* 
ERVIN H . EPSTEIN, JR., M.D., ALLEN HAN, A.B., AND CEDRIC H. L_ SHACKLETON, PH.D. 
Dermatology Division of the Medical Service, San Fmnci.<co General Hospital Medical Center, and the Departments of Dermatology, 
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Patients with recessive X-linked ichthyosis lack activ-
ity of the enzyme steroid sulfatase. One of the more 
striking clinical findings in these patients is the improve-
ment in stratum corneum shedding in the summer. Since 
vitamin D is one steroid responsive to sunlight, we ex-
amined whether or not vitamin D:~ sulfate is a substrate 
for steroid sulfatase. Enzyme preparations active 
against other sulfated steroids caused no desulfation of 
vitamin D:1 sulfate. 
Among the most interesting recent insights into the biochem-
istry of epidermal differentiation is the finding of steroid sulfa-
tase deficiency in patients with recessive X-linked ichthyosis 
(RXLI) [1,2]. This enzyme ca talyzes the desulfation of sulfa ted 
sterols and steroids. We and others have been studying how 
this enzyme and its substrates or products may control epider-
mal shedding. Clinically, we have been particularly impressed 
with the summertime moulting of excess stratum corneum of 
these patients and, because of the temperate climate and foggy 
winters of San Francisco, we have been reluctant to a ttribute 
the great clinical improvement solely to differ ences in ambient 
humidity. Reduced humidity might explain brittleness of th e 
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RXLI: recessive X- linked ichthyosis 
stratum corneum, but it does not relate intuitively to its thick-
ening. One system of steroids in the epidermis with well-studied, 
biochemical diffe rences in summer and winter is that of vitamin 
D and its derivatives. 
Vitamin D:~ sulfate (D:JSO.) was described first as a water-
soluble form of vitamin D of quantita tive importance in milk 
[3,4]. Others have shown that D:~SO,, has only weak antirachi tic 
potency and furthermore is present in smaller amounts in milk 
than thought originally [5-9]. Nonetheless, we believed D,$04 
might offer a clue in linking stero id sulfa tase deficiency and 
summertime moulting of RXLI stratum corneum, and so we 
investigated whether stero id sulfatase ca n desulfate chemically 
prepared DaSO.,. 
MATERIALS AND METHODS 
["1-ll - D :~SO ., was prepared by published techniques [5,6,10]. In brief, 
4 t~C i of r"Hl-0:~ (N ew England Nuclear, 22 Ci/mmol) in 1 ml of dJ·y 
pyridine was incuba ted under nitrogen with 50 mg of pulverized sui-
ramie acid for 30 min at 95°C wi th intermittent sonication. The pyridine 
was removed under a s tream of nitrogen, and the material was chJ"o-
matographed on a 1.5 X 25 em column of Sephadex LH-20. Using a 
chloroform:methanol solvent system (l :l , v/ v) saturated wi th NaCI 
r I I, 121, the elution peaks of free ste rols and s tero l monosulfates were 
at 30 and 85 ml, respective ly. The material elu ting between 80 and 90 
ml was dried, redissolved in wa ter, and desa lted by passing t hrough a 
Sep-Pak C ," cartridge (Waters Associa tes, Milford, Massachusetts) 
[ 13]. The methanol eluant of the cartridge contained the sulfated 
vita min D:~ . 
Th e identity of" the synthesized D:~SO., was con finn ed by 4 methods 
of ana lysis of unlabeled material prepal"ed by the same techniques: (1) 
de te rmining the elu tion volume from LH-20 as described above; (2) 
dete rmining the secondary ion mass spect rum (SIMS) by Kra tos 
MS50S mass spectrometer [14,15) (the sample was placed in glycerol 
on a copper probe tha t was inserted in to the mass spectrometer souJ·ce, 
bombarded wit.h a primary beam of cs+ ions, and negative ions pro-
duced from the sample were collec ted and recorded) ; (3) hydJ·olyzing 
the synthetic product by solvolysis, silylat ion of the freed material 
(hexamethyld isilazane:trimethylchloros ilane, 4:1) , and analyzing by gas 
chromatography on an OV -1 fused-s ilica column; and (4) determining 
the elec tron impact mass spectrum of the trimethylsily l derivative of 
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solvo lyzed vitamin D:~SO. , on a KraLos MS25S mass spectrometer. 
So lvolysis was e ffected by incubating t he sample at 40°C for 24 h in 
acidified ethyl acetate, washing iL with 1 M NaOH, and dry ing iL with 
a nhydrous Na"SO.,. In addition, ultravio let absorption spectra were 
recorded in ethanol with a Hewlett-Packard 8450A spectrophotometer. 
For assay of desu lfation , a suspension of washed microsomes from 
human placenta in 0.014 M Tris buffer, pH 8.0, was added to 13 X 100 
mm glass Lubes containing dried a liquoLs of [ "H]-D:~SO., (or ["H]-de-
hydroepiandroste rone sulf'ate-["H]-DHEAS-as a "positive" control) , 
a nd t he mix ture was sonicated and incubated at 37°C for 3 h. After 
incubation, 2 tech niques were used to detect any ["H]-D:, released by 
desulfation. T he first was to dry the mixture under nitrogen, dissolve 
t h e residue in chloroform:methanol, and pass t his material over the 
same LH-20 colu mn to separate any desu lfated, earlier-elu ting material. 
The second was to add benzene to the mixture, vortex, and determine 
any rad ioact ivity in the upper, organic phase. The latter technique is 
identical to t he standard assay used to detect desulfation of ["H]-
DHEAS [16). W hen studied directly, we found that at least 75% of 
["HlD" is extracted in to benzene out of aqueous solu tion under such 
cond itions. 
RESULTS 
D :JSO., produced by chemica] su]fation appeared to be au-
thentic by a ll cri teria examined. Thus, at least 95% of t he 
CHJD:~ was converted to material elu t ing late fro m LH-20 (85 
ml e lu t ion volume) as expected for a sterol sulfate. When 
s ulfa mic acid was omitted from the 95°C incubation, no mate-
rial elu ted at this late position. Also, the secondary ion mass 
spectrum had a base peak at m/z 463, representing the correct 
mass of the negative ion (M-H) - (M = mass of free acid ) of 
vitamin D ,.SO, (Fig 1). Thu·d, the trimethylsily l ether derivative 
of solvolyzed material gave 2 major peaks on gas cluomatog-
raphy representing the pyro- and isopyro-cyclized forms of 
vitamin D:~. The retention t imes of the major components (29.45 
and 30.80 methylene units, respectively) were identical to those 
of authentic vitamin D:,. Du·ect insertion probe mass spectral 
analysis of the t rimethylsilyl derivative of the solvolyzed vi-
tamin D,.SO,, indicated that the molecular ion was at m/z 456. 
The fragment ions formed were identical to those formed from 
auth entic vitamin D,. trimethylsilyl ether. Finally, the ul travi-
olet spectrum of vitamin D,.S04 (Fig 2) was appropriate with a 
maximum absorbance at 265 nm and minimum at 227 nm, 
indicating the presence of the 5,6-cis-triene structure. 
When ["H]-D,.SO., (10- 7 M final concentration) was incubated 
with human placental microsomes, there was no release of 
("H]D,., as determined by lack of earlier-elut ing material on 
LH-20 chromatography. In contrast, chemical removal of the 
sulfate by solvolysis resulted in shift of a ll the radioactivity to 
earlier elu t ion. Also, no enzymatic desulfation was detected by 
extraction of ["H)-sterol in to benzene-at the end of the incu-
bation with active enzyme, 5% of the radioactivity was extracted · 
into t he benzene phase whereas 8% was extracted when the 
enzyme was omitted from the incubation mixture. 
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Fie 1. Negative ion secondary ion mass spectrum of vitamin D:.S04 • 
Inset, Structure of vitamin D:. sulfate. 
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F I G 2. Ultraviolet absorption spectrum of vitamin D:~SO., dissolved 
in ethanol. The maximum absorbance occurs at 265 nm and the 
minimum at 227 nm. 
To demonstrate that the microsomal suspension contained 
active steroid sul fatase, ["H]-DHEAS (10- 7 M final concentra-
tion) was incubated simultaneously in parallel experiments 
using the same condit ions. Whereas 5% of the radioactivity was 
extracted in to the benzene phase when enzyme was omitted, 
90% was extracted when the microsomes were present during 
the incubation . Similarly, enzymatic desulfation of CHJ-
DHEAS could be detected readily by earlier elution of product 
on LH-20 chromatography. 
DISCUSSION 
Several steroids and sterols, including the sulfated forms of 
DHEAS, estrogens, testosterone, and cholesterol, can be desul-
fated by steroid sulfatase [17]. It is uncertain whether that 
enzymatic activity is a function of a single enzyme molecule or 
of a family of enzymes [18]. In RXLI, desulfation of all sulfated 
sterols studied is absent, suggesting that there is one enzyme 
with a fairly broad specificity for sulfated sterols and steroids. 
However, it is clear from the study reported here that that 
specificity is not so broad as to include D3SO,,, and this suggests 
that an intact Bring is required for enzymatic action. We are 
able to detect desulfation of CH]-DHEAS at a substrate con-
centration of 10- 10 M, a level 5 orders of magnitude less than 
the K,. for that substrate. Hence it seems likely that we would 
have detected some desulfation of [aH]-D:1SO.,, even if the K,. 
had been much greater than t hat for ["H]-DHEAS. 
The lack of activity against D:1SO., might explain why most 
investigations have found that this molecule has such weak 
antirachitic activity. However, we have not excluded the pos-
sibili ty that other t issues might contain an enzyme able to 
desulfate D3SO,, or even t hat human placenta might contain 
such an enzyme that is not bound to membranes. Nonetheless, 
it is clea1· that preparations with active steroid sulfatase do not 
desuifate DaSO.,. 
T he inabili ty of steroid sulfatase to desulfate D:1S04 does not 
diminish our interest in leaming why patients with RXLI moult 
each spring, and we are continuing our efforts to understand 
the biochemical basis of this dramatic clinical change. 
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Stimulation of Hamster Sebaceous Glands by Epidermal .Growth Factor 
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Subcutaneous injection of epidermal growth factor 
(EGF) into the pinna of adult female and castrated male 
Syrian hamsters resulted in an increase in the number 
of cells p er sebaceous gland unit. The effect of EGF on 
the sebaceous cell number was localized to the treated 
ear and accompanied by epidermal hyperplasia. The 
inje ction of testosterone into the ear also produced an 
increase in the cell number. When testosterone and EGF 
w ere injected toge ther, the two hormones exerted an 
additive effect on the sebaceous glands of female ham-
sters. This is the first demonstration of a sebotrophic 
action of this polypeptide hormone. 
The size and secretory activity of the sebaceous glands are 
influenced not only by androgens [1) and other steroids, but 
also by other nonsteroidal facto rs. In the rat, thyroxine and a -
melanocyte stimulating hormone have been shown to produce 
significant stimulation of sebaceous gland function [2-4]. Tis-
sue-specific mitotic inhibitors, termed chalones, have also been 
Manuscript received April 26, 1982; accepted for publication October 
26, 1982. 
Heprin t t·equests to: J onathan R Matias, Orentreich Foundation for 
t he Advancement of Science, Inc., 910 F ift h Avenue, New York, New 
York 10021. 
Abbreviations: 
EGF: epidermal growth factor 
proposed as modulators of cell division under normal physio-
logic conditions. Bullough and Lawrence [5] have extracted a 
chalone which inhibits mitosis in the sebaceous glands of the 
mouse. 
Epidermal growth factor (EGF) , a low-molecular-weight 
polypeptide chain consisting of 53 amino acids, belongs to a 
group of naturally occurring peptides that stimulate the prolif-
eration of diverse cellular systems both in vivo [6-8] and in 
vitro [9,10]. Induction of epidermal hyperplasia and hyperke-
ratinization by EGF when administered in vivo is well docu-
mented [7,11]. However, little is known about the effect ofEGF 
on skin appendages. Since the sebaceous glands ar e epidermally 
derived structures, we have studied the effect of EGF on seba-
ceous glands. 
MATERIALS AND METHODS 
Anima.ls 
Adult, sexually mature Syrian golden ha msters (> 3 months of age, 
110-120 g) were obtained from a randomly bred colony main tained in 
our la borato ry. The animals were housed in groups of 3-4 animals per 
cage and ma in tained at a constant photoperiod (1 4 h of light, 10 h of 
darkness). Food (Purina Laboratory Chow) and drinking water were 
provided ad libi tum. 
Chemicals 
EGF was purchased from Collaborative Research, Inc. (Waltham, 
Massachusetts) in lyophilized form and resolubilized with 0.9% saline 
